Skip to content

Oncologie

09/01/2020
Oncologie

The added value of geriatric assessment in evaluating a patient’s Health-Related Quality-of-Life: A study in ≥70-year-old early-stage invasive breast cancer patients.

Eur J Cancer Care (Engl). 2020 Sep;29(5):e13278. doi: 10.1111/ecc.13278. Epub 2020 Jun 18.PMID: 32557904dr. Brouwers Barbara
06/12/2023
Oncologie

TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer.

Clin Cancer Res. 2019 Mar 15;25(6):1766-1773. doi: 10.1158/1078-0432.CCR-18-1943. Epub 2018 Sep 12.PMID: 30209161dr. Brouwers Barbara
05/01/2018
Oncologie

Circulating tumor cells and survival in abiraterone- and enzalutamide-treated patients with castration-resistant prostate cancer.

Prostate. 2018 May;78(6):435-445. doi: 10.1002/pros.23488. Epub 2018 Feb 12.PMID: 29431193dr. Brouwers Barbara
06/12/2023
Oncologie

Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis.

Genome Med. 2018 Nov 21;10(1):85. doi: 10.1186/s13073-018-0595-5.PMID: 30458854dr. Brouwers Barbara
03/01/2018
Oncologie

The effect of adjuvant chemotherapy on symptom burden and quality of life over time; a preliminary prospective observational study using individual data of patients aged ≥70 with early stage invasive breast cancer.

J Geriatr Oncol. 2018 Mar;9(2):152-162. doi: 10.1016/j.jgo.2017.10.001. Epub 2017 Nov 20.PMID: 29167064dr. Brouwers Barbara
08/01/2022
Oncologie

Long term outcome data from the EORTC 75111-10114 ETF/BCG randomized phase II study: Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer, followed by T-DM1 after progression.

Breast. 2022 Aug;64:100-111. doi: 10.1016/j.breast.2022.05.004. Epub 2022 May 20.PMID: 35636341dr. Brouns Katiadr. Vandevivere Hanneir. Gotelaere Frankydr. Dewulf Bram dr. Debouver Phebedr. Celen Stefaniedr. Van den Steen Elke dr. Linden Evelynedr. De Coninck Brechtdr. Schögler Astrid
06/01/2022
Oncologie

Health-related quality of life in older patients with HER2+ metastatic breast cancer: Comparing pertuzumab plus trastuzumab with or without metronomic chemotherapy in a randomised open-label phase II clinical trial.

J Geriatr Oncol. 2022 Jun;13(5):582-593. doi: 10.1016/j.jgo.2022.01.009. Epub 2022 Jan 31.PMID: 35101364dr. Brouwers Barbara
06/12/2023
Oncologie

Dynamic alterations of immunosenescence-related genes in older women with breast cancer receiving chemotherapy: A prospective study.

Transl Oncol. 2022 Nov;25:101527. doi: 10.1016/j.tranon.2022.101527. Epub 2022 Sep 3.PMID: 36067542dr. Brouwers Barbara
06/12/2023
Oncologie

Robotic Staging of Cervical Cancer With Simultaneous Detection of Primary Pelvic and Secondary Para-Aortic Sentinel Lymph Nodes: Reproducibility in a First Case Series.

Front Surg. 2022 Jun 16;9:905083. doi: 10.3389/fsurg.2022.905083. eCollection 2022.PMID: 35784928dr. De Cuypere Evelinedr. Van Trappen Philippedr. Roels Sarah
06/06/2022
Oncologie

Prospective non-interventional BELOVA/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer: a study of the Belgian and Luxembourg Gynaecological Oncology Group.

Int J Gynecol Cancer. 2022 Jun 6;32(6):753-760. doi: 10.1136/ijgc-2021-003190.PMID: 35063943 Clinical Trial.dr. Claes Nele
02/01/2021
Oncologie

Effect of lipegfilgrastim administration as prophylaxis of chemotherapy-induced neutropenia on dose modification and incidence of neutropenic events: real-world evidence from a non-interventional study in Belgium and Luxembourg.

Acta Clin Belg. 2021 Feb;76(1):10-15. doi: 10.1080/17843286.2019.1646539. Epub 2019 Aug 9.PMID: 31399016 Clinical Trial.dr. Claes Nele
06/12/2023
Oncologie

Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group.

Lancet Oncol. 2018 Mar;19(3):323-336. doi: 10.1016/S1470-2045(18)30083-4. Epub 2018 Feb 9. PMID:dr. Brouwers Barbara
11/01/2018
Oncologie

Low levels of intra-tumoural T cells in breast cancer identify clinically frail patients with shorter disease-specific survival.

J Geriatr Oncol. 2018 Nov;9(6):606-612. doi: 10.1016/j.jgo.2018.03.021. Epub 2018 Apr 21. PMID: 29685380dr. Brouwers Barbara
06/12/2023
Oncologie

Age-related microRNAs in older breast cancer patients: biomarker potential and evolution during adjuvant chemotherapy.

BMC Cancer. 2018 Oct 22;18(1):1014. doi: 10.1186/s12885-018-4920-6.dr. Brouwers Barbara
Geen podcAZts gevonden...
Geen media gevonden...

29 februari 2024

Multidiscipliniaire aanpak van rectumkanker (niet gemetastaseerd)